Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Entresto Patent Expiry to Weigh on Novartis as Profit Seen Falling in 2026

Novartis Kisqali adds one more year of survival benefit for broadest set of patients, including those with aggressive HR+/HER2- advanced breast cancer

Ruchika Sharma11 Sept 2022 3:18 PM IST

Basel: Pharma major, Novartis, has announced results from a new pooled exploratory analysis across the entire MONALEESA Phase III program,...

AstraZeneca discontinues Phase 3 trial of prostate cancer drug Truqap

AstraZeneca Lynparza shows clinically meaningful survival benefit in 1st-line advanced ovarian cancer across two Phase III trials

Ruchika Sharma11 Sept 2022 1:15 PM IST

Ovarian cancer is one of the most common gynaecologic cancers, with a poor prognosis and a high mortality rate.

Bayer begins Phase I study with GIRK4 inhibitor for atrial fibrillation

Bayer, Regeneron anti-blindness drug Eylea shown to work at higher dose, longer intervals

Ruchika Sharma11 Sept 2022 9:00 AM IST

Frankfurt: Bayer said on Thursday that its anti-blindness treatment Eylea, jointly developed with Regeneron, was shown to work as well when given...

USFDA accepts regulatory submission for Pfizer alopecia areata treatment Ritlecitinib

Ruchika Sharma10 Sept 2022 5:15 PM IST

Alopecia areata is an autoimmune disease that has an underlying immuno-inflammatory pathogenesis and develops when the immune system attacks the...

5 arrested with banned cough syrup stock

Gambia probes suspected paracetamol syrup link to dozens of child deaths

Ruchika Sharma10 Sept 2022 2:59 PM IST

"Dozens of children have died in the last three months," Bittaye told Reuters by phone. "Autopsies suggest the possibility of paracetamol."

Sanofi, Regeneron Pharma announce positive Phase 3 data for Dupixent in adults with uncontrolled prurigo nodularis

Ruchika Sharma10 Sept 2022 12:56 PM IST

People with prurigo nodularis experience intense, persistent itch, with thick skin lesions (called nodules) that can cover most of the body.

Cipla Health "Naselin Shubhratri, Prajapati - The Guard" campaign wins Silver at Effie APAC Awards 2022

Ruchika Sharma10 Sept 2022 11:44 AM IST

Naselin has been recognized out of the 29 Indian brands and from the total of 107 brands across the Asia Pacific region which is a gratifying moment...

COVID drug: Zenara Pharma unveils generic of Pfizer Paxlovid at Rs 5,200 per box in India

Ruchika Sharma10 Sept 2022 9:30 AM IST

The tablet which will be sold under the brand name Paxzen.

Heart valve repair device: USFDA warns of potential clip lock issue with Abbott Labs MitraClip

Ruchika Sharma9 Sept 2022 3:30 PM IST

Abbott said it had received increased rate of reports of the devices failing to "establish final arm angle" or "clip opening while locked".

Zydus Lifesciences in-licenses critical drug MonoFerric for CKD patients from Pharmacosmos A/S of Denmark

Ruchika Sharma9 Sept 2022 2:34 PM IST

MonoFerric is indicated for the treatment of iron deficiency in adult patients when oral iron preparations are ineffective or cannot be used or where...

Lupin unveils Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate Oral Solution in US

Ruchika Sharma9 Sept 2022 12:27 PM IST

The product is an osmotic laxative indicated for cleansing of the colon in preparation for colonoscopy in adults.

Novo Nordisk, Zealand Pharma collaborate for ZEGALOGUE for injection

Ruchika Sharma9 Sept 2022 11:33 AM IST

Under the terms of the agreement, Zealand will receive an upfront payment of DKK 25 million and is eligible to receive up to DKK 45 million in...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok